Background: Suppressor 3 of cytokine signaling (SOCS3) hypermethylation has been reported to participate in hepatocellular carcinoma (HCC) development and progression, but conflicting results were published. This study aimed to analyze the clinical effects of SOCS3 hypermethylation in HCC and the effects of sex and age on SOCS3 hypermethylation in HCC.

Methods: Databases were searched for relevant case-control and cohort studies on SOCS3 hypermethylation in HBV-related HCC. In vitro and in vivo studies and studies of patients with serious comorbidities were excluded. Review Manager 5.2 was used to estimate the effects of the results among the selected studies. Forest plots, sensitivity analysis, and bias analysis for the included studies were also conducted.

Results: Finally, 8 relevant studies met the inclusion criteria. A significant difference in SOCS3 hypermethylation in HCC was found between tumor and nontumor groups (the odds ratio [OR] = 2.01, 95% confidence interval [CI]: 1.48-2.73, P < .00001; P for heterogeneity = .39, I2 = 5%). The meta-analysis suggested no significant difference in the effect of sex (OR = 1.00, 95% CI: 0.76-1.31, P = .76; P for heterogeneity = .44, I2 = 0%) and age on SOCS3 hypermethylation in HCC (OR = 1.11, 100% CI: 0.78-1.29, P = .03; P for heterogeneity = .14, I2 = 36%). Limited publication bias was observed in this study.

Conclusion: SOCS3 hypermethylation is associated with HBV-related HCC. Sex and age do not affect the association between SOCS3 hypermethylation and HCC. SOCS3 might be a treatment target for HCC.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556007PMC
http://dx.doi.org/10.1097/MD.0000000000027604DOI Listing

Publication Analysis

Top Keywords

socs3 hypermethylation
24
hypermethylation hbv-related
8
hepatocellular carcinoma
8
sex age
8
hypermethylation hcc
8
hypermethylation
6
studies
6
socs3
5
association socs3
4
hbv-related hepatocellular
4

Similar Publications

DNA methylation and type 2 diabetes: a systematic review.

Clin Epigenetics

May 2024

Division of Nutrition, St. John's Research Institute, St. John's Medical College, St Johns National Academy of Health Sciences, Sarjapura Road, Koramangala, Bangalore, 560034, India.

Objective: DNA methylation influences gene expression and function in the pathophysiology of type 2 diabetes mellitus (T2DM). Mapping of T2DM-associated DNA methylation could aid early detection and/or therapeutic treatment options for diabetics.

Design: A systematic literature search for associations between T2DM and DNA methylation was performed.

View Article and Find Full Text PDF

Hepatic stellate cells (HSC) are key effector cells in liver fibrosis. Upon stimulation, the quiescent HSC undergoes complex morphological and functional changes to transdifferentiate into activated collagen-producing myofibroblasts. DNA/RNA methylations (5mC/mA) are both implicated to participate in hepatic fibrosis, yet their respective roles and specific targets in HSC activation remain elusive.

View Article and Find Full Text PDF
Article Synopsis
  • The JAK/STAT pathway is often disrupted in T-cell acute lymphoblastic leukemia (T-ALL) and lymphoblastic lymphoma (LBL), but there are no approved specific therapies targeting this issue.
  • The study found that hypermethylation of the SOCS3 gene is a common occurrence in T-ALL/LBL, suggesting it could be a potential target for treatment.
  • SOCS3 plays a critical role in regulating the JAK/STAT pathway and its impairment allows for its constant activation, making SOCS3 a promising therapeutic target for these diseases.
View Article and Find Full Text PDF

Excessive fetal growth is associated with DNA methylation alterations in human hematopoietic stem and progenitor cells (HSPC), but their functional impact remains elusive. We implemented an integrative analysis combining single-cell epigenomics, single-cell transcriptomics, and in vitro analyses to functionally link DNA methylation changes to putative alterations of HSPC functions. We showed in hematopoietic stem cells (HSC) from large for gestational age neonates that both DNA hypermethylation and chromatin rearrangements target a specific network of transcription factors known to sustain stem cell quiescence.

View Article and Find Full Text PDF

SOCS3 gene silencing does not occur through methylation and mutations in gastric cancer.

Hum Cell

July 2022

Departments of Biochemistry, Medicine, College of Medicine and Health Sciences, Sultan Qaboos University, PC 123, P. O. Box 35, Muscat, Sultanate of Oman.

Gastric cancer (GC) is ranked the third leading cause of cancer-related deaths worldwide. Mutations and epigenetic alterations in several essential genes, including p53, KRAS, PIK3CA, FAT4 and ARID1A, are often reported. Furthermore, loss of SOCS3 expression was reported in GC, suggesting its tumor suppressor role.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!